Seattle Genetics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Seattle Genetics (SGEN) Tops Q2 EPS by 3c
July 27, 2017 4:43 PM EDTSeattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $108.2 million versus the consensus estimate of $108.8 million.
As of June 30, 2017, Seattle Genetics had $473.0 million in cash, cash equivalents and investments.
2017 Financial... More
